ZONABANTEN.com – Don’t want to lose with Merck, Pfizer also started developing antiviral pills Covid-19.
After going through several stages of testing, it turns out that the antiviral pill Pfizer can cut by up to 89 percent the chance of death or hospitalization for adults at risk of severe disease.
Besides the CEO Pfizer on Friday, November 5 also promised, to make a powerful new weapon to fight the pandemic Covid-19.
Surely the trial results of the antiviral pill Pfizer it surpasses that of the proprietary molnupiravir Merck.
Also Read: Pfizer Antivirus Pills Can Reduce Risk of Severe COVID-19 by Nearly 90 Percent
Molnupiravir alone says it can halve the chances of dying or being hospitalized.
Artificial pills Pfizer dubbed paxlovid, the plan is to get US Government approval by the end of this year.
Pfizer also stated that it plans to submit provisional trial results to the Food and Drug Administration (FDA), on November 25, 2021.
President Joe Biden himself fully supports paxlovid pills, and has secured millions of doses of the drug Pfizer.
– .
